Maharashtra’ Food and Drug Administration has ordered an FIR against eCommerce giant Snapdeal founders Kunal Bahl and other directors for allegedly selling prescription based drugs on the website. The FDA had asked the company to furnish documents pertaining to the distribution and sale
Recent Posts
- Dr Dilip Surana, CMD, Micro Labs Limited featured in the prestigious Healthcare Super Brands Asia
- India’s Rise as a world leader in Semiconductor Manufacturing.
- Redefining Luxury standard of Co-living, Yello Co-living has emerged as top choice for working professionals
- Development Cooperation in a Fractured Global Order.
- Philippine ship rammed by ‘unprovoked’ Chinese coastguard in South China Sea